BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 35487830)

  • 1. Patient-reported Late Effects of Single Fraction Total Body Irradiation for Non-malignant Haematological Disease Transplant Conditioning.
    van Griethuysen J; Gaze MN; Chang YC
    Clin Oncol (R Coll Radiol); 2022 Jul; 34(7):e322. PubMed ID: 35487830
    [No Abstract]   [Full Text] [Related]  

  • 2. Cyclophosphamide plus total body irradiation compared with busulfan plus cyclophosphamide as a conditioning regimen prior to hematopoietic stem cell transplantation in patients with leukemia: a systematic review and meta-analysis.
    Gupta T; Kannan S; Dantkale V; Laskar S
    Hematol Oncol Stem Cell Ther; 2011; 4(1):17-29. PubMed ID: 21460603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of allogeneic haematopoietic stem cell transplantation with intensity-modulated total body irradiation by helical tomotherapy: a 2-year prospective follow-up study.
    Konishi T; Ogawa H; Najima Y; Hashimoto S; Kito S; Atsuta Y; Wada A; Adachi H; Konuma R; Kishida Y; Nagata A; Yamada Y; Kaito S; Mukae J; Marumo A; Noguchi Y; Shingai N; Toya T; Igarashi A; Shimizu H; Kobayashi T; Ohashi K; Doki N; Murofushi KN
    Ann Med; 2022 Dec; 54(1):2616-2625. PubMed ID: 36254468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Single-Center Experience With Hematopoietic Stem Cell Transplantation for Pediatric Acute Lymphoblastic Leukemia: A Modest Pitch for Non-Total Body Irradiation Conditioning Regimens.
    Hamidieh AA; Eslami Shahre Babaki A; Rostami T; Kasaeian A; Koochakzadeh L; Sharifi Aliabadi L; Behfar M; Ghavamzadeh A
    Exp Clin Transplant; 2019 Apr; 17(2):243-250. PubMed ID: 30295587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Late toxicity of a novel allogeneic stem cell transplant using single fraction total body irradiation for hematologic malignancies in children.
    Madden LM; Ngwube AI; Shenoy S; Druley TE; Hayashi RJ
    J Pediatr Hematol Oncol; 2015 Mar; 37(2):e94-e101. PubMed ID: 25333837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fertility after bone marrow transplantation following conditioning with cyclophosphamide and total body irradiation.
    Jacob A; Goodman A; Holmes J
    Bone Marrow Transplant; 1995 Mar; 15(3):483-4. PubMed ID: 7599577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mortality outcomes after busulfan-containing conditioning treatment and haemopoietic cell transplantation in patients with Gilbert's syndrome: a retrospective cohort study.
    McDonald GB; Evans AT; McCune JS; Schoch G; Ostrow JD; Gooley TA
    Lancet Haematol; 2016 Nov; 3(11):e516-e525. PubMed ID: 27968820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of Granulocyte Colony-Stimulating Factor-Combined High-Dose Cytarabine, Cyclophosphamide, and Total Body Irradiation in Allogeneic Hematopoietic Cell Transplantation for Myeloid Malignant Neoplasms.
    Nakamura Y; Tanaka Y; Tanaka M; Yamamoto K; Matsuguma M; Kajimura Y; Tokunaga Y; Yujiri T; Tanizawa Y
    Transplant Proc; 2019 Apr; 51(3):896-900. PubMed ID: 30979482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early toxicity of intensified conditioning with etoposide combined with total body irradiation/cyclophosphamide or busulfan/cyclophosphamide in children undergoing autologous or allogeneic bone marrow transplantation.
    Horstmann M; Kroschke G; Stockschläder M; Betker R; Krüger W; Erttmann R; Kabisch H; Zander A
    Pediatr Hematol Oncol; 1996; 13(1):45-53. PubMed ID: 8718502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Total body irradiation and cyclophosphamide plus antithymocyte globulin regimen is well tolerated and promotes stable engraftment as a preparative regimen before T cell-replete haploidentical transplantation for acute leukemia.
    Fu H; Xu L; Liu D; Liu K; Zhang X; Chen H; Chen Y; Han W; Wang Y; Wang J; Wang F; Huang X
    Biol Blood Marrow Transplant; 2014 Aug; 20(8):1176-82. PubMed ID: 24747336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term outcome after bone marrow transplantation for aplastic anemia using cyclophosphamide and total lymphoid irradiation as conditioning regimen.
    Inamoto Y; Suzuki R; Kuwatsuka Y; Yasuda T; Takahashi T; Tsujimura A; Sugimoto K; Oba T; Terakura S; Atsuta Y; Murata M; Ito M; Kodera Y; Miyamura K
    Biol Blood Marrow Transplant; 2008 Jan; 14(1):43-9. PubMed ID: 18158960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High risk of acute pulmonary toxicity with both myeloablative and non-myeloablative total body irradiation-based conditioning for allogeneic stem cell transplantation.
    Patel P; Dillon M; Niedzwiecki D; Crowell KA; Horwitz ME; Wang E; Kelsey CR
    Bone Marrow Transplant; 2024 Jan; 59(1):150-152. PubMed ID: 37923832
    [No Abstract]   [Full Text] [Related]  

  • 13. Final height of patients who underwent bone marrow transplantation for hematological disorders during childhood: a study by the Working Party for Late Effects-EBMT.
    Cohen A; Rovelli A; Bakker B; Uderzo C; van Lint MT; Esperou H; Gaiero A; Leiper AD; Dopfer R; Cahn JY; Merlo F; Kolb HJ; Socié G
    Blood; 1999 Jun; 93(12):4109-15. PubMed ID: 10361107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haploidentical vs haplo-cord transplant in adults under 60 years receiving fludarabine and melphalan conditioning.
    van Besien K; Artz A; Champlin RE; Guarneri D; Bishop MR; Chen J; Gergis U; Shore T; Liu H; Rondon G; Mayer SA; Srour SA; Stock W; Ciurea SO
    Blood Adv; 2019 Jun; 3(12):1858-1867. PubMed ID: 31217161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early and late neurological complications after reduced-intensity conditioning allogeneic stem cell transplantation.
    Barba P; Piñana JL; Valcárcel D; Querol L; Martino R; Sureda A; Briones J; Delgado J; Brunet S; Sierra J
    Biol Blood Marrow Transplant; 2009 Nov; 15(11):1439-46. PubMed ID: 19822304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose total-body irradiation and fludarabine followed by hematopoietic cell transplantation from HLA-identical sibling donors do not induce complete T-cell donor engraftment in most patients with progressive hematologic diseases.
    Fernández-Avilés F; Urbano-Ispizua A; Aymerich M; Rovira M; Martínez C; Talarn C; Jiménez M; Carreras E; Montserrat E
    Exp Hematol; 2003 Oct; 31(10):934-40. PubMed ID: 14550809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Efficacy and safety of TBI+rATG-based conditioning regimen for haploidentical allogeneic hematopoietic stem cell transplantation in 11 cases of chemotherapy-resistant advanced peripheral T-cell lymphoma].
    Xu R; Li S; Liu HX; Wei DL; Jiang Y; Wang JJ; Liu SS; Wang C; Zhu J
    Zhonghua Xue Ye Xue Za Zhi; 2023 Jul; 44(7):578-581. PubMed ID: 37749039
    [No Abstract]   [Full Text] [Related]  

  • 18. Haploidentical bone marrow transplants for haematological malignancies using non-myeloablative conditioning therapy and post-transplant immunosuppression with cyclophosphamide: results from a single Australian centre.
    Bilmon IA; Kwan J; Gottlieb D; Kerridge I; McGurgan M; Huang G; George B; Hertzberg M; Bradstock KF
    Intern Med J; 2013 Feb; 43(2):191-6. PubMed ID: 22646924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignant and benign thyroid nodules after total body irradiation preceding hematopoietic cell transplantation during childhood.
    Vivanco M; Dalle JH; Alberti C; Lescoeur B; Yakouben K; Carel JC; Baruchel A; Léger J
    Eur J Endocrinol; 2012 Aug; 167(2):225-33. PubMed ID: 22619350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors Influencing Pulmonary Toxicity in Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation in the Setting of Total Body Irradiation-Based Myeloablative Conditioning.
    Abugideiri M; Nanda RH; Butker C; Zhang C; Kim S; Chiang KY; Butker E; Khan MK; Haight AE; Chen Z; Esiashvili N
    Int J Radiat Oncol Biol Phys; 2016 Feb; 94(2):349-59. PubMed ID: 26853343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.